Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients

Recombinant poxviruses (vaccinia and fowlpox) expressing tumor-associated antigens are currently being evaluated in clinical trials as cancer vaccines to induce tumor-specific immune responses that will improve clinical outcome. To test whether a diversified prime and boost regimen targeting NY-ESO-...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Odunsi, Kunle, Matsuzaki, Junko, Karbach, Julia, Neumann, Antje, Mhawech-Fauceglia, Paulette, Miller, Austin, Beck, Amy, Morrison, Carl D., Ritter, Gerd, Godoy, Heidi, Lele, Shashikant, duPont, Nefertiti, Edwards, Robert, Shrikant, Protul, Old, Lloyd J., Gnjatic, Sacha, Jäger, Elke
Formato: Artigo
Idioma:Inglês
Publicado: National Academy of Sciences 2012
Assuntos:
Biological Sciences
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3326498/
https://ncbi.nlm.nih.gov/pubmed/22454499
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1117208109
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares